Amber Implants Completes Enrolment of First-In-Human Clinical Trial of its VCFix® Spinal System

THE HAGUE, Netherlands, June 11, 2024 /PRNewswire/ — Amber Implants (‘Amber’ or ‘the Company’), an innovative medical technology company developing next-generation implants for spinal injuries, today announces that it has completed enrolment of its first-in-human clinical trial with its…